晚发型急性纤维蛋白性机化性肺炎损害肺移植远期功能与生存
该研究回顾了468例肺移植患者的移植肺活检,按移植后≤90天或>90天区分早发与晚发急性纤维蛋白性机化性肺炎(AFOP)。晚发AFOP与更差的CLAD无生存期和移植物生存期相关,并特异性关联限制性移植物综合征、供者特异性抗体及气道和血液嗜酸性粒细胞增多。
要点
- 晚发AFOP(>90天)患者CLAD无生存期中位仅2.42年,移植物生存期中位4.39年。
- 晚发AFOP与限制性移植物综合征风险显著升高相关(OR 28.57)。
- 晚发AFOP与循环供者特异性抗体及气道、血液嗜酸性粒细胞增多相关。
核心结论
- 晚发型AFOP与更差预后及CLAD(尤其限制性移植物综合征)高风险相关。
- 晚发型AFOP可能参与限制性移植物综合征的早期发病过程。
研究设计与样本
- 回顾性队列研究,纳入2011-2017年鲁汶大学医院468例肺移植患者的移植肺活检。
- AFOP分为早发新发(移植后≤90天)和晚发新发(移植后>90天)。
主要发现
- 早发AFOP检出24例(5%),晚发AFOP检出30例(6%)。
- 晚发AFOP患者CLAD无生存期中位2.42年,显著低于早发或无AFOP患者(p<0.0001)。
- 晚发AFOP与限制性移植物综合征相关(OR 28.57,95%CI 11.34-67.88;p<0.0001)。
- 晚发AFOP患者移植物生存期中位4.39年,显著低于早发或无AFOP患者(p<0.0001)。
- 晚发AFOP与循环供者特异性抗体相关(OR 4.75,95%CI 2.17-10.60;p=0.0004),并与气道和血液嗜酸性粒细胞增多相关(p=0.043和p=0.045)。
临床怎么用
- 肺移植后晚发AFOP提示预后不良,应加强CLAD监测与随访。
- 晚发AFOP患者需关注限制性移植物综合征、供者特异性抗体及嗜酸性粒细胞增多。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute fibrinous and organising pneumonia (AFOP) after lung transplantation is associated with a rapid decline in pulmonary function. However, the relation with chronic lung allograft dysfunction (CLAD) remains unclear. We investigated the association between detection of AFOP in lung allograft biopsies with clinically important endpoints.We reviewed lung allograft biopsies from 468 patients who underwent lung transplantation at the University Hospitals Leuven (2011-2017). AFOP was categorised as early new-onset (≤90 days post-transplant) or late new-onset (>90 days post-transplant); and associated with CLAD-free survival, graft survival, donor-specific antibodies, airway and blood eosinophilia.Early and late AFOP was detected in 24 (5%) and 30 (6%) patients, respectively. CLAD-free survival was significantly lower in patients with late AFOP (median survival 2.42 years; p<0.0001) compared with patients with early or without AFOP and specifically associated with development of restrictive allograft syndrome (OR 28.57, 95% CI 11.34-67.88; p<0.0001). Similarly, graft survival was significantly lower in patients with late AFOP (median survival 4.39 years; p<0.0001) compared with patients with early AFOP or without AFOP. Late AFOP was furthermore associated with detection of circulating donor-specific antibodies (OR 4.75, 95% CI 2.17-10.60; p=0.0004) compared with patients with early or without AFOP, and elevated airway and blood eosinophilia (p=0.043 and p=0.045, respectively) compared with early AFOP patients.Late new-onset AFOP is associated with a worse prognosis and high risk of CLAD development, specifically restrictive allograft syndrome. Our findings indicate that late new-onset AFOP might play a role in the early pathogenesis of restrictive allograft syndrome.
引用
- Vanstapel A, Verleden SE, Weynand B, et al. Late-onset "acute fibrinous and organising pneumonia" impairs long-term lung allograft function and survival. Eur Respir J. 2020. PMID: 32381491. doi:10.1183/13993003.02292-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。